Taste Dysfunction in Head and Neck Cancer Due to Radiation Dose Taste Dysfunction in Head and Neck Cancer Due to Radiation Dose
Lowering the dose of radiotherapy delivered to the oral cavity could reduce the risk of taste dysfunction in patients with head and neck cancer, say researchers.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Expert Alert: Options for laryngeal regeneration
PHOENIX, Ariz. — Mayo Clinic is using 3D printing as a new option to heal the larynx after cancer or traumatic injury. David Lott, M.D., a Mayo Clinic otolaryngologist and head and neck surgeon, is an expert who can speak about a pioneering procedure using 3D bioimplants and tissue engineering to regenerate the larynx, more commonly known as the voice box. Dr. Lott also is the associate director of the Center for Regenerative Medicine at… (Source: Mayo Clinic Arizona News)
Source: Mayo Clinic Arizona News - August 2, 2022 Category: Hospital Management Source Type: news

The Latest Breakthroughs That Could Help Bladder Cancer Patients
Toward the end of the 19th century, a New York City surgeon named Dr. William Coley purposely injected one of his patients with streptococcal bacteria. Coley wasn’t crazy. He hoped the bacterial infection would stimulate an immune response that would slow the spread of his patient’s cancer, which was inoperable. The experiment worked; the patient’s tumor shrank. For the next 40 years, Coley and his research collaborators would test similar remedies on more than 1,000 cancer patients. They had failures but also many successes, especially among people with bone or soft-tissue cancers. Today, Coley is someti...
Source: TIME: Health - July 27, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

Scientists create nanoparticle that helps fight solid tumors
Researchers from Wake Forest University School of Medicine have discovered a possible new approach in treating solid tumors through the creation of a novel nanoparticle. Solid tumors are found in cancers such as breast, head and neck, and colon cancer. In the study, Xin Ming, associate professor of cancer biology at Wake Forest University School of Medicine, and his team used a nanoparticle to deliver a small molecule called ARL67156 to promote an anti-tumor immune response in mouse models of colon,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 14, 2022 Category: Pharmaceuticals Authors: Atrium Health Wake Forest Baptist Source Type: news

Mitochondrial Protein Fuels Spread of Head and Neck Cancer 
Head and neck cancer cells lacking the peptide involved in energy production were less likely to metastasize in mice. (Source: The Scientist)
Source: The Scientist - July 8, 2022 Category: Science Tags: News & Opinion Source Type: news

Mitochondrial Protein Fuels Spread of Head and Neck Cancer & nbsp;
Removing a protein involved in energy production from the mitochondria of head and neck cancer cells drastically reduced the number of cells that metastasized in mice. (Source: The Scientist)
Source: The Scientist - July 8, 2022 Category: Science Tags: News & Opinion Source Type: news

What does the new cancer vaccine trial mean for a cure to the illness?
None of the eight head and neck cancer sufferers, who had a high chance of relapse, have seen their tumours return four months after getting the vaccine in a trial at a UK cancer centre. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2022 Category: Consumer Health News Source Type: news

European Commission approves Roche ’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvantTecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive careTecentriq is now the firstand only cancer immunotherapy available for certain people with early-stage NSCLC in EuropeToday ’s approval marksTecentriq ’s sixth lung cancer indication in EuropeBasel, 09 June 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq ® (atezolizumab) as an adjuvant treatment, following complete resection and platinum-based chemotherapy, for adu...
Source: Roche Investor Update - June 9, 2022 Category: Pharmaceuticals Source Type: news

European Commission approves Roche ’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvantTecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive careTecentriq is now the firstand only cancer immunotherapy available for certain people with early-stage NSCLC in EuropeToday ’s approval marksTecentriq ’s sixth lung cancer indication in EuropeBasel, 09 June 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq ® (atezolizumab) as an adjuvant treatment, following complete resection and platinum-based chemotherapy, for adu...
Source: Roche Media News - June 9, 2022 Category: Pharmaceuticals Source Type: news

Cost of living crisis will lead to more cancer patient survival rates
THE spiralling cost-of-living crisis will lead to more cancer patients relapsing and could hit survival rates, research suggests. A study of 555 Canadian patients with head and neck cancer found a low income was detrimental to their chances of recovery. (Source: Daily Express - Health)
Source: Daily Express - Health - June 7, 2022 Category: Consumer Health News Source Type: news

Novel Agent Lessens Mucositis in Head and Neck Cancers
(MedPage Today) -- CHICAGO – Severe oral mucositis among patients undergoing radiation and platinum-based chemotherapy for locally-advanced head and neck cancers can be significantly reduced by the novel agent avasopasem manganese, researchers... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 6, 2022 Category: Hematology Source Type: news

Judson appointed Charles W. Ohse Professor of Surgery (Otolaryngology)
Benjamin Judson ’s research interests include investigating outcomes and quality in head and neck cancer therapy. His appointment begins immediately. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 6, 2022 Category: Universities & Medical Training Source Type: news

Is Throat Cancer a Head and Neck Cancer?
Title: Is Throat Cancer a Head and Neck Cancer?Category: Diseases and ConditionsCreated: 5/17/2022 12:00:00 AMLast Editorial Review: 5/17/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2022 Category: Cancer & Oncology Source Type: news

Most smokers with head and neck cancer STILL puffed on cigarettes two years after treatment
Scientists at the University of Minnesota found of the 61 patients who were still alive two years after treatment, as many as 38 - or 60 percent - were still smokers. (Source: the Mail online | Health)
Source: the Mail online | Health - May 12, 2022 Category: Consumer Health News Source Type: news

F.D.A. Authorizes Underwear to Protect Against S.T.I.s During Oral Sex
It ’s the first time underwear has been authorized for this purpose, and it provides a new choice for protection where the few options have been unpopular. (Source: NYT Health)
Source: NYT Health - May 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Sex Head and Neck Cancer Lingerie and Underwear Sexually Transmitted Diseases Women and Girls Mouth Vagina Human Papillomavirus (HPV) Food and Drug Administration your-feed-science your-feed-healthcare Source Type: news